{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:30Z","timestamp":1790380050274,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1093\/jac\/dky229","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T15:13:09Z","timestamp":1527088389000},"page":"2360-2373","source":"Crossref","is-referenced-by-count":36,"title":["In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis"],"prefix":"10.1093","volume":"73","author":[{"given":"Sara","family":"Teixeira de Macedo Silva","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Ultraestrutura Celular Hertha Meyer, Instituto de Biof\u00edsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Biologia Estrutural e Bioimagem, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Visbal","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Metrologia, Qualidade e Tecnologia, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseane","family":"Lima Prado Godinho","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Ultraestrutura Celular Hertha Meyer, Instituto de Biof\u00edsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Biologia Estrutural e Bioimagem, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A","family":"Urbina","sequence":"additional","affiliation":[{"name":"Instituto Venezolano de Investigaciones Cient\u00edficas, Caracas, Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley","family":"de Souza","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Ultraestrutura Celular Hertha Meyer, Instituto de Biof\u00edsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Biologia Estrutural e Bioimagem, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliany","family":"Cola Fernandes Rodrigues","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Ultraestrutura Celular Hertha Meyer, Instituto de Biof\u00edsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Biologia Estrutural e Bioimagem, Rio de Janeiro, Brazil"},{"name":"N\u00facleo Multidisciplinar de Pesquisa UFRJ-Xer\u00e9m, Divis\u00e3o Biologia, Universidade Federal do Rio de Janeiro, Campus Duque de Caxias, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"key\n\t\t\t\t20180823025341_dky229-B1","doi-asserted-by":"crossref","first-page":"e35671.","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823025341_dky229-B2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.idc.2012.03.001","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"26","author":"Goto","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20180823025341_dky229-B3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180823025341_dky229-B4","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20180823025341_dky229-B5","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-007-7305-9_1","article-title":"Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure","volume":"74","author":"Rodrigues","year":"2014","journal-title":"Subcell Biochem"},{"key":"key\n\t\t\t\t20180823025341_dky229-B7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4269\/ajtmh.14-0259","article-title":"Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study","volume":"92","author":"Sundar","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180823025341_dky229-B8","author":"WHO","year":"2010"},{"key":"key\n\t\t\t\t20180823025341_dky229-B9","doi-asserted-by":"crossref","first-page":"815023.","DOI":"10.1155\/2015\/815023","article-title":"Advances in development of new treatment for leishmaniasis","volume":"2015","author":"de Menezes","year":"2015","journal-title":"Biomed Res Int"},{"key":"key\n\t\t\t\t20180823025341_dky229-B10","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.2174\/0929867322666150319120337","article-title":"Sterol biosynthesis pathway as an alternative for the anti-protozoan parasite chemotherapy","volume":"22","author":"de Macedo-Silva","year":"2015","journal-title":"Curr Med Chem"},{"key":"key\n\t\t\t\t20180823025341_dky229-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12639-010-0006-3","article-title":"Drug targets in Leishmania","volume":"34","author":"Chawla","year":"2010","journal-title":"J Parasit Dis"},{"key":"key\n\t\t\t\t20180823025341_dky229-B12","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1021\/cr400552x","article-title":"Fruitful decade for antileishmanial compounds from 2002 to late 2011","volume":"114","author":"Hussain","year":"2014","journal-title":"Chem Rev"},{"key":"key\n\t\t\t\t20180823025341_dky229-B13","doi-asserted-by":"crossref","first-page":"642502.","DOI":"10.1155\/2009\/642502","article-title":"Sterol biosynthesis pathway as target for anti-trypanosomatid drugs","volume":"2009","author":"de Souza","year":"2009","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"key\n\t\t\t\t20180823025341_dky229-B14","doi-asserted-by":"crossref","first-page":"e83247","DOI":"10.1371\/journal.pone.0083247","article-title":"In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis","volume":"8","author":"de Macedo-Silva","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180823025341_dky229-B15","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1128\/AAC.01150-15","article-title":"Potent in vitro antiproliferative synergism of combinations of ergosterol biosynthesis inhibitors against Leishmania amazonensis","volume":"59","author":"de Macedo-Silva","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0924-8579(02)00273-X","article-title":"In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease","volume":"21","author":"Urbina","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180823025341_dky229-B17","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.01742-09","article-title":"Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi","volume":"54","author":"Diniz","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J Biomol Screen"},{"key":"key\n\t\t\t\t20180823025341_dky229-B19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled study","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180823025341_dky229-B20","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkm428","article-title":"New and emerging treatments for fungal infections","volume":"61","author":"Pasqualotto","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B21","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ejmech.2008.10.028","article-title":"The structure-bioavailability approach in antifungal agents","volume":"44","author":"Grudzie\u0144","year":"2009","journal-title":"Eur J Med Chem"},{"key":"key\n\t\t\t\t20180823025341_dky229-B22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2307\/3274932","article-title":"Metabolism of Schizotrypanum cruzi Chagas. I. Effect of culture age and substrate concentration on respiratory rate","volume":"46","author":"Warren","year":"1960","journal-title":"J Parasitol"},{"key":"key\n\t\t\t\t20180823025341_dky229-B23","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1039\/c1ay05219e","article-title":"Tetrazolium salt based methods for high-throughput evaluation of anti-parasite chemotherapy","volume":"3","author":"Henriques","year":"2011","journal-title":"Anal Methods"},{"key":"key\n\t\t\t\t20180823025341_dky229-B24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10495-017-1397-8","article-title":"KH-TFMDI, a novel sirtuin inhibitor, alters the cytoskeleton and mitochondrial metabolism promoting cell death in Leishmania amazonensis","volume":"22","author":"Ver\u00e7oza","year":"2017","journal-title":"Apoptosis"},{"key":"key\n\t\t\t\t20180823025341_dky229-B25","first-page":"876021","article-title":"Antiproliferative, ultrastructural, and physiological effects of amiodarone on promastigote and amastigote forms of Leishmania amazonensis","volume":"2011","author":"de Macedo-Silva","year":"2011","journal-title":"Mol Biol Int"},{"key":"key\n\t\t\t\t20180823025341_dky229-B26","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1128\/AAC.01616-07","article-title":"In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative biochemical, and ultrastructural effects","volume":"52","author":"Rodrigues","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B27","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AAC.47.9.2966-2970.2003","article-title":"S-adenosyl-l-methionine inhibitors: \u039424-sterol methyltransferase and \u039424(28)-sterol methylreductase as possible agents against Paracoccidioides brasiliensis","volume":"47","author":"Visbal","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B28","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180823025341_dky229-B29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1991.44.536","article-title":"Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease","volume":"44","author":"Barral","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180823025341_dky229-B30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0074-02761994000300027","article-title":"The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia","volume":"89","author":"Lainson","year":"1994","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"key\n\t\t\t\t20180823025341_dky229-B31","doi-asserted-by":"crossref","first-page":"e2999","DOI":"10.1371\/journal.pntd.0002999","article-title":"In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis","volume":"8","author":"Coelho","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180823025341_dky229-B32","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/AAC.43.12.2910","article-title":"Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases","volume":"43","author":"Al-Abdely","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B33","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/AAC.01498-10","article-title":"Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole","volume":"55","author":"Paniz-Mondolfi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180823025341_dky229-B34","first-page":"193","article-title":"Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole","volume":"14","author":"Watt","year":"2013","journal-title":"Curr Drug Metab"},{"key":"key\n\t\t\t\t20180823025341_dky229-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(96)00345-7","article-title":"Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by \u039424(25) sterol methyl transferase inhibitors and their combinations with ketoconazole","volume":"8","author":"Vivas","year":"1997","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180823025341_dky229-B36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1550-7408.2001.tb00195.x","article-title":"The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin permeabilization","volume":"48","author":"Rodrigues","year":"2001","journal-title":"J Eukaryot Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/9\/2360\/25523142\/dky229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T07:38:04Z","timestamp":1571384284000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/9\/2360\/5048318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,7,3]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky229","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,7,3]]}}}